IntelligenceOverview
NewsBriefingJournalismTesseract
ExposureReportsNeural WebPlayersGeopoliticsSignal Map
MarketsMarket SignalsPulse
Entity

Invivyd

Invivyd is a biotechnology company developing a monoclonal antibody treatment as an alternative to Covid vaccines.

Why it’s in the news: It is in the news because its lead Covid antibody treatment received positive preliminary results from a late-stage trial.

Explore Invivyd in the interactive graph

Latest on Invivyd

  • STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await

Connections

3 entities linked to Invivyd across the news graph.

Also connected to (3)
FDACOVIDSTAT
Open the interactive Neural Web →Intelligence Briefs